IL135983A0 - Adenovirus vectors and method for reducing homologous recombination phenomena - Google Patents

Adenovirus vectors and method for reducing homologous recombination phenomena

Info

Publication number
IL135983A0
IL135983A0 IL13598398A IL13598398A IL135983A0 IL 135983 A0 IL135983 A0 IL 135983A0 IL 13598398 A IL13598398 A IL 13598398A IL 13598398 A IL13598398 A IL 13598398A IL 135983 A0 IL135983 A0 IL 135983A0
Authority
IL
Israel
Prior art keywords
homologous recombination
adenovirus vectors
recombination phenomena
reducing
reducing homologous
Prior art date
Application number
IL13598398A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9513447&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL135983(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL135983A0 publication Critical patent/IL135983A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
IL13598398A 1997-11-17 1998-11-17 Adenovirus vectors and method for reducing homologous recombination phenomena IL135983A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714383A FR2774699B1 (fr) 1997-11-17 1997-11-17 Methode de reduction des evenements de recombinaison homologue
PCT/FR1998/002453 WO1999025861A2 (fr) 1997-11-17 1998-11-17 Vecteurs adenoviraux et methode de reduction des evenements de recombinaison homologue

Publications (1)

Publication Number Publication Date
IL135983A0 true IL135983A0 (en) 2001-05-20

Family

ID=9513447

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13598398A IL135983A0 (en) 1997-11-17 1998-11-17 Adenovirus vectors and method for reducing homologous recombination phenomena
IL135983A IL135983A (en) 1997-11-17 2000-05-04 Adenoviral vectors and a method for reducing the frequency of inter- or intra-molecular homologous recombination between chromosomal nucleic acids and extra-chromosomal nucleic acids

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL135983A IL135983A (en) 1997-11-17 2000-05-04 Adenoviral vectors and a method for reducing the frequency of inter- or intra-molecular homologous recombination between chromosomal nucleic acids and extra-chromosomal nucleic acids

Country Status (17)

Country Link
US (1) US6410298B1 (xx)
EP (1) EP1032695B1 (xx)
JP (1) JP4376454B2 (xx)
KR (2) KR100796060B1 (xx)
CN (1) CN1201013C (xx)
AT (1) ATE393234T1 (xx)
AU (1) AU759531B2 (xx)
BR (1) BR9814210A (xx)
CA (1) CA2309315C (xx)
CZ (1) CZ299797B6 (xx)
DE (1) DE69839403T2 (xx)
FR (1) FR2774699B1 (xx)
HU (1) HU226018B1 (xx)
IL (2) IL135983A0 (xx)
NO (1) NO329784B1 (xx)
PL (1) PL196606B1 (xx)
WO (1) WO1999025861A2 (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2799472B1 (fr) * 1999-10-07 2004-07-16 Aventis Pharma Sa Preparation d'adenovirus recombinants et de banques adenovirales
US7653769B2 (en) * 2006-12-14 2010-01-26 International Business Machines Corporation Management of devices connected to infiniband ports
US6821775B1 (en) * 2000-02-11 2004-11-23 Genvec, Inc. Viral vector encoding pigment epithelium-derived factor
US6591543B2 (en) * 2000-04-14 2003-07-15 Kenneth P. Sabine Top water lure with highly active propeller
KR20010064682A (ko) * 2000-07-01 2001-07-11 김재호 Ｅ1ｂ가 감쇠된 아데노바이러스를 이용한 ｃｄ／5－ｆｃ및 ｈｓｖ－1 ｔｋ／ｇｃｖ의 이중 자멸 유전자 시스템
DE10045687B4 (de) * 2000-09-15 2006-07-06 MICROMUN Privates Institut für Mikrobiologische Forschung GmbH Biotechnikum Greifswald Expressionskassetten und Adenovirusvektoren
US20030087438A1 (en) * 2001-11-02 2003-05-08 Genvec, Inc. E1-revertant-free adenoviral composition
US20030158112A1 (en) 2002-02-15 2003-08-21 Johns Hopkins University School Of Medicine Selective induction of apoptosis to treat ocular disease
CA2507036A1 (en) * 2002-12-02 2004-06-17 Genvec, Inc. Materials and methods for treating ocular-related disorders
CA2559436A1 (en) * 2004-03-12 2005-09-29 Genvec, Inc. Materials for treating vascular leakage in the eye
US20060188481A1 (en) * 2005-02-22 2006-08-24 Saitama Medical School Methods for prophylactically or therapeutically treating an animal for an ocular-related disorder
TW200840869A (en) * 2007-01-30 2008-10-16 Transgene Sa Papillomavirus vaccine
ES2416361T3 (es) * 2007-05-15 2013-07-31 Transgene Sa Vectores para la expresión de múltiples genes
HUE029744T2 (en) 2007-07-26 2017-04-28 Uniqure Ip Bv Baculovirus vectors containing different codon sequences with repeated coding sequences
AU2009317517B2 (en) * 2008-11-21 2014-12-04 Bavarian Nordic A/S Vector comprising multiple homologous nucleotide sequences
EP2389443B1 (en) 2009-01-23 2018-11-14 Roger Williams Hospital Retroviral vectors encoding multiple highly homologous non-viral polypeptides and the use of same
WO2012021730A2 (en) * 2010-08-11 2012-02-16 Genvec, Inc. Respiratory syncytial virus (rsv) vaccine
EP2784155B1 (en) * 2011-11-24 2018-06-13 Viromed Co. Ltd. Adenovirus producing novel cell line and the use thereof
US9014637B1 (en) * 2013-09-27 2015-04-21 Intel Corporation Dynamic switching frequency control of an on-chip or integrated voltage regulator
CN108203706B (zh) * 2017-11-30 2021-03-26 陕西师范大学 一种用于提高高容量腺病毒包装效率的辅助腺病毒
CN112877358B (zh) * 2021-02-07 2023-02-03 上海市第一人民医院 一种基于5型腺病毒序列的重组质粒及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726285B1 (fr) * 1994-10-28 1996-11-29 Centre Nat Rech Scient Adenovirus depourvus de particules contaminantes viables, preparation et utilisation
ES2300105T3 (es) * 1995-03-24 2008-06-01 Genzyme Corporation Vectores adenoviricos para terapia genica.
US5994128A (en) * 1995-06-15 1999-11-30 Introgene B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy

Also Published As

Publication number Publication date
JP2003504004A (ja) 2003-02-04
KR100796060B1 (ko) 2008-01-21
KR20010032146A (ko) 2001-04-16
NO20002504L (no) 2000-05-15
DE69839403T2 (de) 2009-05-28
HU226018B1 (en) 2008-03-28
EP1032695B1 (fr) 2008-04-23
WO1999025861A3 (fr) 1999-07-01
CZ299797B6 (cs) 2008-11-26
HUP0101827A3 (en) 2003-08-28
CN1201013C (zh) 2005-05-11
CN1278302A (zh) 2000-12-27
JP4376454B2 (ja) 2009-12-02
PL196606B1 (pl) 2008-01-31
NO329784B1 (no) 2010-12-20
KR20070103483A (ko) 2007-10-23
PL340601A1 (en) 2001-02-12
FR2774699A1 (fr) 1999-08-13
AU3129400A (en) 2000-12-14
WO1999025861A2 (fr) 1999-05-27
HUP0101827A2 (hu) 2001-09-28
CZ20001791A3 (cs) 2000-08-16
FR2774699B1 (fr) 2003-10-03
BR9814210A (pt) 2000-10-03
US6410298B1 (en) 2002-06-25
AU759531B2 (en) 2003-04-17
EP1032695A2 (fr) 2000-09-06
DE69839403D1 (de) 2008-06-05
ATE393234T1 (de) 2008-05-15
IL135983A (en) 2008-11-26
CA2309315C (fr) 2011-06-14
CA2309315A1 (fr) 1999-05-27
NO20002504D0 (no) 2000-05-15

Similar Documents

Publication Publication Date Title
IL135983A0 (en) Adenovirus vectors and method for reducing homologous recombination phenomena
HU9603155D0 (en) Papillomavirus vaccines
IL121614A0 (en) System for the expression of heterologous antigens as fusion proteins
MX9802764A (es) Promotor homologo fuerte procedente de un hamster.
PL339860A1 (en) Methods of modulating the action of serine/threonine protein kinase by means of compounds based on 5-azaquinoxaline
EP0886644A4 (en) LARGE WAVELENGTH HANDLING FLUORESCENT PROTEINS
IL130198A0 (en) Methods for purifying viruses
EP1047446A4 (en) COMPOSITION OF VACCINE AGAINST HERPES SIMPLEX VIRUS AND METHOD OF USING SAME
IT1266734B1 (it) Gruppo per la molatura di lastre di vetro.
ZA997011B (en) Attenuated forms of bovine viral diarrhea virus.
IL117459A0 (en) DNA encoding papillomavirus type 18
NZ238833A (en) Equine herpesvirus-4 gh or gc polypeptides, nucleic acids encoding them and vaccines therefrom
WO1998018950A3 (de) Aav-dna mit helfervirus-sequenzen
AU7471098A (en) Recombinant influenza viruses expressing tumor-associated antigens as antitum or agents
IL127430A0 (en) Generating replicating moleucules in vivo
DE69531678D1 (de) Rekombinatie viren,ihre herstellung und ihre verwendung in der gentherapie
GB9422687D0 (en) Process for generating DNA markers
AU1801699A (en) Creation of heteroimmunity amongst ctx$g(f): methods and compounds for the construction of improved (v. cholerae) vaccines
ZA91752B (en) Process for the enzymatic cleavage or recombinant proteins using iga proteases
IL131297A0 (en) Method for the production of vaccines against cell surface proteins
ZA956164B (en) Process for preparing viral vectors.
ZA200007318B (en) Particles of HCV envelope proteins: use for vaccination.
AU8892398A (en) Method for the graphitisation of carbon articles
ZA9810532B (en) Method for the integration of foreign DNA into eukaryotic genomes
EP0623971A3 (en) Improved method of connecting heating elements.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed